TCG News

TCG’s iPartners represents a new ideation advisory group comprised of leading academic investigators and biotech entrepreneurs. Working closely with TCG’s Swanson Fellows and our core investment team, this group is dedicated to crafting innovative new drug discovery company concepts, drawing on their deep scientific expertise, academic and industry networks, and entrepreneurial intuition. The iPartners consist […]

The Column Group announced the recruitment of Dr. Eric Olson to the firm’s renowned group of Science Partners. Dr. Olson is the founding Chair of the Department of Molecular Biology at The University of Texas Southwestern Medical Center. He also founded the Center for Regenerative Science and Medicine at UT Southwestern, which is advancing new

The Column Group announces the hiring of Dr. John Josey. Previously, Dr. Josey served as the President, Chief Executive Officer and a member of the Board of Directors of Peloton Therapeutics, from 2013 until its acquisition by Merck in 2019. He joined Peloton in 2011 as the first employee in the role of President and

The Column Group announced the recruitment of Dr. Helen Hobbs to the firm’s renowned group of Science Partners. Dr. Hobbs is Professor of Internal Medicine and Molecular Genetics at the University of Texas Southwestern Medical Center. She is also an investigator at the Howard Hughes Medical Institute.

The Column Group announces the hiring of Dr. Leon Chen. Previously, Dr. Chen was a Venture Partner at Orbimed. Prior to that he was a Partner at Skyline Ventures. Dr. Chen was also a founder of KAI Pharmaceuticals, acquired by Amgen in 2012.

The Column Group announces the promotion of Dr. JJ Kang from Principal to Partner. Dr. Kang has been with TCG since 2015.

The Column Group announced the recruitment of Dr. Vishva Dixit to the firm’s renowned group of Science Partners.  Dr. Dixit is Vice President of Physiological Chemistry at Genentech.  He is a member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences and a Foreign Member, European

The Column Group announced the recruitment of Dr. Huda Zoghbi and Dr. Charles Zuker to the firm’s renowned group of Science Partners. Dr. Huda Zoghbi is a professor in the Departments of Pediatrics, Molecular and Human Genetics, Neurology and Neuroscience at Baylor College of Medicine. She is also an investigator at the Howard Hughes Medical

The Column Group announces that Dr. Robert Tjian has joined as a Discovery Partner. Dr. Tjian recently served as president of the Howard Hughes Medical Institute from April 2009 through August 2016 and was co-founder of Tularik which was acquired by Amgen in 2004. He is a professor of biochemistry and molecular biology at the